Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02038010
Title BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications

Her2-receptor positive breast cancer

Therapies

Ado-trastuzumab emtansine + Alpelisib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.